SEC Filings
Dr. Reddy's Wins Brazil Clearance For Generic Semaglutide, With Aché As Launch Partner
Brazil's regulator approved the once-weekly diabetes pen in two sizes, and the company puts the country's semaglutide market at about USD 244.6 million.